SCHEMBL11962307

SCHEMBL11962307

Cc1ccc2ccc3ccc(-c4ccc(Oc5cccc(-c6ccc7ccc8ccc(C)nc8c7n6)c5)cc4)nc3c2n1

nearest known ligand 0.46

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 1/20 0.42
▸ CCR1 P32246 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ CCR5 P51681 1/20 0.42
▸ PARP1 P09874 1/20 0.40
▸ MAP4K4 O95819 3/20 0.40
▸ MAOA P21397 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ P2RX3 P56373 1/20 0.39
▸ MCL1 Q07820 1/20 0.37
▸ METAP2 P50579 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11962332 0.88 MCL1 (0.47) RAB9APARP1MAP4K4MAOAMAOB
SCHEMBL11962278 0.88 RAB9A (0.54) ADORA1CCR1RAB9ACCR5PARP1
SCHEMBL17174120 0.84 MCL1 (0.48) RAB9APARP1MAOAMAOBMCL1
SCHEMBL17174130 0.84 MCL1 (0.48) RAB9APARP1MAOAMAOBMCL1
SCHEMBL11962305 0.82 MAP4K4 (0.46) CCR1CCR5PARP1MAP4K4
SCHEMBL17178156 0.82 MAP4K4 (0.46) RAB9APARP1MAP4K4MAOBP2RX3
SCHEMBL17146615 0.82 CCR1 (0.58) CCR1RAB9ACCR5PARP1METAP2
SCHEMBL10032248 0.82 CCR1 (0.58) CCR1RAB9ACCR5PARP1METAP2
SCHEMBL17174124 0.81 P2RX3 (0.44) RAB9AMAP4K4P2RX3
SCHEMBL11962342 0.81 NPC1 (0.42) RAB9APARP1MAP4K4MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9054319-B2 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2015-06-09 — — US disclosed
US-9054319-B2 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2015-06-09 — — US disclosed
US-8759819-B2 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2014-06-24 — — US disclosed
US-8759819-B2 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2014-06-24 — — US disclosed
US-20140131680-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2014-05-15 — — US disclosed
US-20140131680-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2014-05-15 — — US disclosed
US-20120199817-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. 2012-08-09 — — US disclosed
US-20120199817-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. 2012-08-09 — — US disclosed
US-20100283043-A1 ORGANIC EL ELEMENT IDEMITSU LOSAN CO., LTD. 2010-11-11 — — US disclosed
US-20100283043-A1 ORGANIC EL ELEMENT IDEMITSU LOSAN CO., LTD. 2010-11-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120199817-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FTO, EML4, SLC43A1 ADORA1 2782/4885CCR1 4282/4885RAB9A 559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback